Physical symptoms appear to predict cancer prognosis

July 26, 2004

Physical symptoms that impact quality of life, such as nausea and shortness of breath, may predict shorter survival for patients with terminal cancer. A new study published July 26, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, finds a patient's symptoms and results of quality of life assessments may provide important clues to an individual patient's prognosis. Psychosocial factors, such as anxiety or spiritual distress, did not predict shorter survival. A free abstract of the study will be available via Wiley InterScience (http://www.interscience.wiley.com/cancer-newsroom) upon embargo.

In order to give the most appropriate treatment options to newly diagnosed cancer patients, physicians often assess a patient's health-related quality of life (hrQoL), along with tumor characteristics that predict the aggressiveness of the disease and, ultimately, outcome (i.e., response rate to treatments, overall survival, time to progression, and survival in years). In the field of palliative care, length of survival and quality of life are paramount. Research has demonstrated that clinical factors and tumor characteristics predict survival in terminal cancer patients, but there is limited data on the predictive value of hrQoL measures, such as physical and psychological symptoms. Existing research suggests that physical symptoms, not psychosocial symptoms, predict length of survival. However, the conclusions of these studies are weakened by methodological shortfalls.

To overcome previous study design flaws, Dr. Antonio Vigano of the McGill University Health Center and his colleagues investigated the relationship between survival and multiple hrQoL variables among 1002 patients at the beginning of or at a later stage of terminal cancer (colorectal, breast, genitourinary, or lung cancer).

The authors found that physical hrQoL factors predicted shorter survival in both groups. The relationship was strongest in the later stage of terminal cancer. Among patients at the later stage, shortness of breath increased the risk of death by 50 percent for all cancer types studied, and weakness increased the risk of death for colorectal (three-fold), breast (five-fold) and genitourinary (four-fold) cancers. Among patients at the onset of the terminal stage of cancer, the risk of death increased 68 percent with nausea/vomiting and 28 percent with shortness of breath. However, other clinical and tumor characteristics more strongly predicted outcome in this group. No predictive value was observed for psychosocial factors, such as anxiety, spiritual distress and lack of insight.

The authors conclude, "our findings indicate that patients presenting with chronic nausea and vomiting, shortness of breath, and weakness are more advanced in the progress toward the terminal wasting associated with cancer than patients who do not present these symptoms" and "patients and families should be reassured that they do not feel they or their relatives are going to die sooner if they are in psychosocial distress."
-end-
Article: "Quality of Life and Survival Prediction in Terminal Cancer Patients: A Multicenter Study," Antonio Vigano, Nora Donaldson, Irene J. Higginson, Eduardo Bruera, Salaheddin Mahmud, Maria Suarez-Almazor, CANCER; Published Online: July 26, 2004 (DOI: 10.1002/cncr.20472); Print Issue Date: September 1, 2004.

Wiley

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.